Medpace Holdings, Inc.
MEDP
Pozycja w akcjach
#1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Cena akcji
$623.55
Kapitalizacja rynkowa
$17.40B
Zmiana (1 dzień)
0.63%
Zmiana (1 rok)
14.54%
Kraj
US
Handel Medpace Holdings, Inc. (MEDP)
Kategoria
Healthcare
Zyski dla Medpace Holdings, Inc. (MEDP)
Zyski w Jun 2026 TTM: $598.92M
Według najnowszych raportów finansowych Medpace Holdings, Inc., obecny zysk firmy wynosi $598.92M. W roku 2024 firma osiągnęła zysk w wysokości $475.92M, wzrost w porównaniu do zysku z roku 2023, który wynosił $335.68M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Medpace Holdings, Inc. od 2013 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $598.92M | 10.43% |
| 2025 | $542.38M | 13.96% |
| 2024 | $475.92M | 41.78% |
| 2023 | $335.68M | 18.67% |
| 2022 | $282.86M | 40.13% |
| 2021 | $201.85M | 19.77% |
| 2020 | $168.53M | 35.01% |
| 2019 | $124.83M | 32.87% |
| 2018 | $93.95M | 64.99% |
| 2017 | $56.95M | 159.35% |
| 2016 | $21.96M | -380.42% |
| 2015 | $-7.83M | -63.17% |
| 2014 | $-21.26M | -154.31% |
| 2013 | $39.15M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $7.61B | 1,170.45% |
US
|
|
| $4.76B | 695.09% |
US
|
|
| $-252.70M | -142.19% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 176.83% |
US
|
